ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
<p>Background. In numerous clinical studies that tried to identify risk factors for progressive renal function loss, the severity of proteinuria correlated with the rate of renal function loss. In patients with chronic renal disease and hypertension the angiotensin converting enzyme (ACE) inhi...
Main Authors: | Tanja Kök, Radovan Hojs |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2002-03-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/1578 |
Similar Items
-
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01) -
PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01) -
Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
by: Azadeh Khalili, et al.
Published: (2021-07-01) -
Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
by: Oghenemega Okoloko, et al.
Published: (2021-11-01) -
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
by: Renata Aiglova, et al.
Published: (2022-09-01)